vs
Elevance Health（ELV）与挪威国家石油公司（EQNR）财务数据对比。点击上方公司名可切换其他公司
Elevance Health的季度营收约是挪威国家石油公司的1.9倍（$49.7B vs $26.0B），Elevance Health净利率更高（1.1% vs -0.8%，领先1.9%），挪威国家石油公司同比增速更快（2.4% vs 1.8%）
Elevance Health是美国知名健康保险公司，2022年6月前名为Anthem, Inc.。按营收规模计算，该公司是全球第七大医疗保健企业，通过Anthem蓝十字蓝盾、加州Anthem蓝十字、Wellpoint、Carelon等附属机构，提供医疗、医药、牙科、精神健康、长期护理、残疾保险等多元服务。
Equinor ASA是总部位于挪威斯塔万格的跨国能源企业，核心业务为油气开采，运营范围覆盖36个国家，同时布局可再生能源、锂矿开采等领域。该公司多次登上福布斯全球2000强榜单，2023年位列第52位，截至2021年共有员工21126名。
ELV vs EQNR — 直观对比
营收规模更大
ELV
是对方的1.9倍
$26.0B
营收增速更快
EQNR
高出0.6%
1.8%
净利率更高
ELV
高出1.9%
-0.8%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $49.7B | $26.0B |
| 净利润 | $547.0M | $-204.0M |
| 毛利率 | 88.9% | 46.6% |
| 营业利润率 | 0.6% | 20.2% |
| 净利率 | 1.1% | -0.8% |
| 营收同比 | 1.8% | 2.4% |
| 净利润同比 | -74.9% | -108.9% |
| 每股收益（稀释后） | $2.56 | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ELVEQNR
| Q1 26 | $49.7B | — | ||
| Q4 25 | $49.7B | — | ||
| Q3 25 | $50.7B | $26.0B | ||
| Q2 25 | $49.8B | $25.1B | ||
| Q1 25 | $48.9B | — | ||
| Q4 24 | $45.4B | — | ||
| Q3 24 | $45.1B | $25.4B | ||
| Q2 24 | $43.9B | — |
净利润ELVEQNR
| Q1 26 | $547.0M | — | ||
| Q4 25 | $547.0M | — | ||
| Q3 25 | $1.2B | $-204.0M | ||
| Q2 25 | $1.7B | $1.3B | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $418.0M | — | ||
| Q3 24 | $1.0B | $2.3B | ||
| Q2 24 | $2.3B | — |
毛利率ELVEQNR
| Q1 26 | 88.9% | — | ||
| Q4 25 | 88.9% | — | ||
| Q3 25 | 89.4% | 46.6% | ||
| Q2 25 | 89.4% | 49.3% | ||
| Q1 25 | 89.8% | — | ||
| Q4 24 | 86.8% | — | ||
| Q3 24 | 88.7% | 48.5% | ||
| Q2 24 | 89.0% | — |
营业利润率ELVEQNR
| Q1 26 | 0.6% | — | ||
| Q4 25 | 0.6% | — | ||
| Q3 25 | 2.6% | 20.2% | ||
| Q2 25 | 4.9% | 22.8% | ||
| Q1 25 | 6.5% | — | ||
| Q4 24 | 1.5% | — | ||
| Q3 24 | 3.1% | 27.1% | ||
| Q2 24 | 6.3% | — |
净利率ELVEQNR
| Q1 26 | 1.1% | — | ||
| Q4 25 | 1.1% | — | ||
| Q3 25 | 2.3% | -0.8% | ||
| Q2 25 | 3.5% | 5.2% | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 2.3% | 9.0% | ||
| Q2 24 | 5.2% | — |
每股收益（稀释后）ELVEQNR
| Q1 26 | $2.56 | — | ||
| Q4 25 | $2.56 | — | ||
| Q3 25 | $5.32 | $-0.08 | ||
| Q2 25 | $7.72 | $0.50 | ||
| Q1 25 | $9.61 | — | ||
| Q4 24 | $1.88 | — | ||
| Q3 24 | $4.36 | $0.82 | ||
| Q2 24 | $9.85 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.5B | $8.1B |
| 总债务越低越好 | $31.9B | — |
| 股东权益账面价值 | $43.9B | $40.6B |
| 总资产 | $121.5B | $135.8B |
| 负债/权益比越低杠杆越低 | 0.73× | — |
8季度趋势，按日历期对齐
现金及短期投资ELVEQNR
| Q1 26 | $9.5B | — | ||
| Q4 25 | $9.5B | — | ||
| Q3 25 | $8.7B | $8.1B | ||
| Q2 25 | $8.6B | — | ||
| Q1 25 | $7.5B | — | ||
| Q4 24 | $8.3B | — | ||
| Q3 24 | $7.9B | $6.2B | ||
| Q2 24 | $6.5B | — |
总债务ELVEQNR
| Q1 26 | $31.9B | — | ||
| Q4 25 | $31.9B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $30.9B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益ELVEQNR
| Q1 26 | $43.9B | — | ||
| Q4 25 | $43.9B | — | ||
| Q3 25 | $44.0B | $40.6B | ||
| Q2 25 | $43.7B | — | ||
| Q1 25 | $42.5B | — | ||
| Q4 24 | $41.3B | — | ||
| Q3 24 | $43.8B | $44.4B | ||
| Q2 24 | $42.2B | — |
总资产ELVEQNR
| Q1 26 | $121.5B | — | ||
| Q4 25 | $121.5B | — | ||
| Q3 25 | $122.7B | $135.8B | ||
| Q2 25 | $121.9B | — | ||
| Q1 25 | $119.7B | — | ||
| Q4 24 | $116.9B | — | ||
| Q3 24 | $116.5B | — | ||
| Q2 24 | $113.0B | — |
负债/权益比ELVEQNR
| Q1 26 | 0.73× | — | ||
| Q4 25 | 0.73× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.75× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $6.3B |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ELVEQNR
| Q1 26 | — | — | ||
| Q4 25 | $84.0M | — | ||
| Q3 25 | $1.1B | $6.3B | ||
| Q2 25 | $2.1B | $2.5B | ||
| Q1 25 | $1.0B | — | ||
| Q4 24 | $706.0M | — | ||
| Q3 24 | $2.7B | $6.5B | ||
| Q2 24 | $447.0M | — |
自由现金流ELVEQNR
| Q1 26 | — | — | ||
| Q4 25 | $-209.0M | — | ||
| Q3 25 | $775.0M | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $821.0M | — | ||
| Q4 24 | $384.0M | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $124.0M | — |
自由现金流率ELVEQNR
| Q1 26 | — | — | ||
| Q4 25 | -0.4% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 3.6% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | 0.3% | — |
资本支出强度ELVEQNR
| Q1 26 | — | — | ||
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.7% | — |
现金转化率ELVEQNR
| Q1 26 | — | — | ||
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.95× | — | ||
| Q2 25 | 1.18× | 1.88× | ||
| Q1 25 | 0.47× | — | ||
| Q4 24 | 1.69× | — | ||
| Q3 24 | 2.63× | 2.84× | ||
| Q2 24 | 0.19× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
